节点文献

右美托咪定预防造影剂诱导急性肾损伤机制的研究进展

Research progress on the possible mechanism of dexmedetomidine in preventing contrast-induced acute kidney injury

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李金泽李凯赵国庆

【Author】 LI Jinze;LI Kai;ZHAO Guoqing;Department of Anesthesiology, China-Japan Union Hospital of Jilin University;

【通讯作者】 赵国庆;

【机构】 吉林大学中日联谊医院麻醉科

【摘要】 造影剂诱导急性肾损伤(CI-AKI)是在血管内应用造影剂(CM)进行诊断或治疗性血管造影干预后观察到的医源性急性肾损伤(AKI)。造影剂通过肾小管毒性、肾内血管收缩和活性氧(ROS)的过量产生等方面导致肾功能受损。右美托咪定(DEX)是一种选择性α2肾上腺素能受体激动药,具有良好的抗氧化、抗炎作用,在围手术期的器官保护作用日益突显。DEX对患者术后肾功能具有保护作用。本文旨在对DEX对CI-AKI的预防作用、可能机制以及临床应用的研究进展作一综述。

【Abstract】 Contrast-induced acute kidney injury(CI-AKI) is an iatrogenic acute kidney injury(AKI) observed after diagnostic or therapeutic angiographic interventions with the intravascular application of contrast media(CM). CM leads to impaired renal function through tubular toxicity, intrarenal vasoconstriction, and excessive reactive oxygen species(ROS) production. Dexmedetomidine(DEX) is a selective α2 adrenergic receptor agonist that has been shown to have good antioxidant and anti-inflammatory effects, and its organ protective effect in the perioperative period is increasingly prominent. Several studies have found that DEX has an excellent protective effect on postoperative renal function. This article aims to explore the protective effect, possible mechanism, and clinical application of DEX in CI-AKI.

  • 【文献出处】 临床麻醉学杂志 ,Journal of Clinical Anesthesiology , 编辑部邮箱 ,2024年05期
  • 【分类号】R614
  • 【下载频次】45
节点文献中: 

本文链接的文献网络图示:

本文的引文网络